AIM
NTUS

Aigen Investment Management’s Natus Medical Inc NTUS Stock Holding History

Aigen Investment Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,140
Closed -$285K – 797
2021
Q1 		$285K Sell
11,140
-9,808
-47% -$251K 0.04% 436
2020
Q4 		$420K Buy
+20,948
New +$410K 0.05% 441

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aigen Investment Management's NTUS Position: Q2 2021 in Review

Aigen Investment Management sold out of Natus Medical Inc (NTUS) in Q2 2021, closing a stake of 11,140 shares — an estimated $285K sold.

Aigen Investment Management first reported a position in NTUS in Q4 2020 and held it in 2 quarters. The position peaked at $420K in Q4 2020. 170 funds tracked by Wall St. Rank hold NTUS as of Q2 2021.

  • Aigen Investment Management reported no remaining Natus Medical Inc position as of Q2 2021 after selling out during the quarter.
  • Aigen Investment Management sold 11,140 Natus Medical Inc shares in Q2 2021, an estimated $285K.
  • Aigen Investment Management first reported a position in Natus Medical Inc in Q4 2020 and held it in 2 quarters.
  • Aigen Investment Management's Natus Medical Inc position peaked at $420K in Q4 2020.
  • 170 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2021.

Based on Aigen Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.